6-Pyruvoyl-tetrahydropterin synthase deficiency with generalized dystonia and diurnal fluctuation of symptoms: a clinical and molecular study

Mov Disord. 1997 May;12(3):408-11. doi: 10.1002/mds.870120321.

Abstract

We report the case of a 44-year-old woman with a partial 6-pyruvoyl tetrahydropterin synthase (6-PTS) deficiency, whose predominant clinical symptom was generalized dystonia with marked diurnal fluctuation. Dystonia was present in the eyelids, oromandibular region, trunk, and extremities (Meige syndrome plus double hemiplegia-like dystonia). A marked and sustained positive response to levodopa was observed. A molecular genetic study revealed a homozygous mutation (I114V) in the 6-PTS gene. This study indicates that genetic abnormality in the 6-PTS gene may be a hereditary dystonia disorder. We speculate that our patient has residual 6-PTS activity in the central nervous system, such as in the liver, and we suggest that residual, but insufficient production of tetrahydrobiopterin may play an important role in causing diurnal fluctuation of symptoms.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Alcohol Oxidoreductases / deficiency*
  • Antiparkinson Agents / administration & dosage
  • Antiparkinson Agents / therapeutic use
  • Base Sequence
  • Benserazide / administration & dosage
  • Benserazide / therapeutic use
  • Circadian Rhythm*
  • Drug Therapy, Combination
  • Dystonia / drug therapy
  • Dystonia / enzymology*
  • Dystonia / genetics
  • Female
  • Homozygote
  • Humans
  • Levodopa / administration & dosage
  • Levodopa / therapeutic use
  • Molecular Sequence Data
  • Phosphorus-Oxygen Lyases*
  • Point Mutation
  • Polymerase Chain Reaction
  • Pterins / urine

Substances

  • Antiparkinson Agents
  • Pterins
  • Levodopa
  • Benserazide
  • Alcohol Oxidoreductases
  • Phosphorus-Oxygen Lyases
  • 6-pyruvoyltetrahydropterin synthase